Centers

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

EU-OPENSCREEN

TEST

Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in 2017, with the aim to facilitate advancement of academic drug discovery and drug development research by leveraging innovations and sciences...
Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

info here

Read more

Partnerships

Events

Jobs

GSK and MD Anderson to co-develop new cancer therapeutics

GlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the...

 
View all

UCSF And Genentech to Develop Drugs to Treat Neurodegenerative Diseases

University of California, San Francisco (UCSF) and Genetech have entered into a research collaboration to develop drugs to treat neurodegenerative diseases. Genetech will be providing funding to researchers at UCSF Small Molecule Discovery Center...

 
View all

Sanofi to Collaborate with UCSF to Develop New Drugs to Treat Diabetes

University of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All